TM

Trevor Martin

Co-founder and CEO

Mammoth Biosciences

Mammoth Biosciences Pipeline

DrugIndicationPhase
MB-111UndisclosedPreclinical
NanoCas for Extrahepatic EditingPotential muscular/other disordersPreclinical